Andrew Parratt is a senior pharma/biotech executive with more than 25 years of Commercial, Strategy and Operations experience. He is currently the Vice President of Commercial Planning and Operations for Karuna Therapeutics. Andrew has built his career turning great science into commercial success, orchestrating cross-functional collaborations to identify synergies and enable organizations to scale and commercialize. He develops long-term roadmaps and corporate strategies that define how individual functions are interdependent in their efforts to move promising compounds from Phase I to maturity.
Andrew holds a Postgraduate Diploma in Marketing from the Chartered Institute of Marketing in London. He earned a First Class Honors Bachelor of Science in Chemistry for Europe (French) from the University of Surrey, UK / Ecole de Chimie, France.
As commercial outsourcing becomes more sophisticated, it allows for greater innovation as small and ambitious biotech companies are given the strategic power to bring to market needed healthcare solutions.